Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001860010-23-000002

Options or other derivatives

  • Chief Commercial Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ORTH ANDREW C. Chief Commercial Officer 2023-02-28 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D
ORTH ANDREW C. Chief Commercial Officer 2023-02-28 Grant or award · Performance Stock Units +10,000 10,000 D
Loading xslF345X03/wf-form4_167762789935314.xml…